Faculty Collaboration Database

Living donor liver transplantation in patients with hepatitis C. Liver Transpl 2003 Nov;9(11):S52-7

Date

10/31/2003

Pubmed ID

14586896

DOI

10.1053/jlts.2003.50256

Scopus ID

2-s2.0-0242539726   29 Citations

Abstract

1. Hepatitis C virus (HCV) is the most common indication for living donor liver transplantation (LDLT). 2. Preliminary evidence suggests that HCV may occur earlier and may be more severe in LDLT recipients. However, current data is inconclusive relative to the impact of recurrent HCV on patient and graft survival in LDLT recipients. 3. Potential mechanisms for differences in severity of HCV in LDLT recipients are discussed. 4. LDLT remains a viable treatment option for selected patients with HCV.

Author List

Zimmerman MA, Trotter JF

Author

Michael A. Zimmerman MD, FACS Professor in the Surgery department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Antiviral Agents
Graft Survival
Hepatitis C
Humans
Immunosuppression
Liver
Liver Cirrhosis
Liver Transplantation
Living Donors
Postoperative Period
Recurrence